MediNet Group Limited
MediNet Group Limited (8161.HK) Stock Competitors & Peer Comparison
See (8161.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 8161.HK | HK$0.46 | +1.11% | 18.9M | 2.39 | HK$0.19 | N/A |
| 6618.HK | HK$48.75 | -3.08% | 156B | 33.85 | HK$1.44 | N/A |
| 6078.HK | HK$17.06 | -0.23% | 10.4B | 16.40 | HK$1.04 | N/A |
| 1951.HK | HK$3.34 | +0.30% | 9B | 30.36 | HK$0.11 | N/A |
| 2273.HK | HK$36.35 | +1.68% | 8.5B | 27.13 | HK$1.34 | +1.49% |
| 2373.HK | HK$26.00 | -3.53% | 6.1B | 24.07 | HK$1.08 | N/A |
| 1515.HK | HK$4.43 | -0.45% | 5.7B | 9.04 | HK$0.49 | +3.24% |
| 2453.HK | HK$5.58 | +0.18% | 4.6B | -8.21 | -HK$0.68 | N/A |
| 3309.HK | HK$1.79 | -1.65% | 2.2B | -16.27 | -HK$0.11 | +1.12% |
| 2219.HK | HK$2.96 | -0.34% | 2B | 9.55 | HK$0.31 | +8.45% |
Stock Comparison
8161.HK vs 6618.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 6618.HK has a market cap of 156B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 6618.HK trades at HK$48.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 6618.HK's P/E ratio is 33.85. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 6618.HK's ROE of +0.08%. Regarding short-term risk, 8161.HK is less volatile compared to 6618.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 6618.HK's competition here
8161.HK vs 6078.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 6078.HK has a market cap of 10.4B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 6078.HK trades at HK$17.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 6078.HK's P/E ratio is 16.40. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 6078.HK's ROE of +0.09%. Regarding short-term risk, 8161.HK is less volatile compared to 6078.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 6078.HK's competition here
8161.HK vs 1951.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1951.HK has a market cap of 9B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1951.HK trades at HK$3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1951.HK's P/E ratio is 30.36. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1951.HK's ROE of +0.03%. Regarding short-term risk, 8161.HK is less volatile compared to 1951.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1951.HK's competition here
8161.HK vs 2273.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2273.HK has a market cap of 8.5B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2273.HK trades at HK$36.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2273.HK's P/E ratio is 27.13. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2273.HK's ROE of +0.13%. Regarding short-term risk, 8161.HK is less volatile compared to 2273.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2273.HK's competition here
8161.HK vs 2373.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2373.HK has a market cap of 6.1B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2373.HK trades at HK$26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2373.HK's P/E ratio is 24.07. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2373.HK's ROE of +0.26%. Regarding short-term risk, 8161.HK is less volatile compared to 2373.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2373.HK's competition here
8161.HK vs 1515.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1515.HK has a market cap of 5.7B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1515.HK trades at HK$4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1515.HK's P/E ratio is 9.04. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1515.HK's ROE of +0.09%. Regarding short-term risk, 8161.HK is less volatile compared to 1515.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1515.HK's competition here
8161.HK vs 2453.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2453.HK has a market cap of 4.6B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2453.HK trades at HK$5.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2453.HK's P/E ratio is -8.21. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2453.HK's ROE of -0.25%. Regarding short-term risk, 8161.HK is less volatile compared to 2453.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2453.HK's competition here
8161.HK vs 3309.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 3309.HK has a market cap of 2.2B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 3309.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 3309.HK's P/E ratio is -16.27. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 3309.HK's ROE of -0.08%. Regarding short-term risk, 8161.HK is less volatile compared to 3309.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 3309.HK's competition here
8161.HK vs 2219.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2219.HK has a market cap of 2B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2219.HK trades at HK$2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2219.HK's P/E ratio is 9.55. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2219.HK's ROE of +0.08%. Regarding short-term risk, 8161.HK is less volatile compared to 2219.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2219.HK's competition here
8161.HK vs 3886.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 3886.HK has a market cap of 1.9B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 3886.HK trades at HK$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 3886.HK's P/E ratio is -9.50. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 3886.HK's ROE of -0.07%. Regarding short-term risk, 8161.HK is less volatile compared to 3886.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 3886.HK's competition here
8161.HK vs 0708.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 0708.HK has a market cap of 1.8B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 0708.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 0708.HK's P/E ratio is -0.07. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 0708.HK's ROE of +0.67%. Regarding short-term risk, 8161.HK is less volatile compared to 0708.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 0708.HK's competition here
8161.HK vs 1526.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1526.HK has a market cap of 1.7B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1526.HK trades at HK$1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1526.HK's P/E ratio is 5.10. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1526.HK's ROE of +0.23%. Regarding short-term risk, 8161.HK is less volatile compared to 1526.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1526.HK's competition here
8161.HK vs 9960.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 9960.HK has a market cap of 1.5B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 9960.HK trades at HK$1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 9960.HK's P/E ratio is -25.33. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 9960.HK's ROE of -0.02%. Regarding short-term risk, 8161.HK is less volatile compared to 9960.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 9960.HK's competition here
8161.HK vs 6639.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 6639.HK has a market cap of 1.5B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 6639.HK trades at HK$2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 6639.HK's P/E ratio is 52.00. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 6639.HK's ROE of +0.01%. Regarding short-term risk, 8161.HK is less volatile compared to 6639.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 6639.HK's competition here
8161.HK vs 1846.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1846.HK has a market cap of 1B. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1846.HK trades at HK$3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1846.HK's P/E ratio is 13.12. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1846.HK's ROE of +0.07%. Regarding short-term risk, 8161.HK is less volatile compared to 1846.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1846.HK's competition here
8161.HK vs 9906.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 9906.HK has a market cap of 906M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 9906.HK trades at HK$1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 9906.HK's P/E ratio is 21.57. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 9906.HK's ROE of +0.05%. Regarding short-term risk, 8161.HK is less volatile compared to 9906.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 9906.HK's competition here
8161.HK vs 0383.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 0383.HK has a market cap of 887M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 0383.HK trades at HK$0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 0383.HK's P/E ratio is 27.33. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 0383.HK's ROE of +0.02%. Regarding short-term risk, 8161.HK is less volatile compared to 0383.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 0383.HK's competition here
8161.HK vs 1989.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1989.HK has a market cap of 812.6M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1989.HK trades at HK$0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1989.HK's P/E ratio is -22.50. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1989.HK's ROE of -0.16%. Regarding short-term risk, 8161.HK is less volatile compared to 1989.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1989.HK's competition here
8161.HK vs 3869.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 3869.HK has a market cap of 704.3M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 3869.HK trades at HK$5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 3869.HK's P/E ratio is -16.77. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 3869.HK's ROE of -0.11%. Regarding short-term risk, 8161.HK is less volatile compared to 3869.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 3869.HK's competition here
8161.HK vs 3689.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 3689.HK has a market cap of 645.4M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 3689.HK trades at HK$1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 3689.HK's P/E ratio is 38.40. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 3689.HK's ROE of +0.04%. Regarding short-term risk, 8161.HK is less volatile compared to 3689.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 3689.HK's competition here
8161.HK vs 2120.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2120.HK has a market cap of 636.1M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2120.HK trades at HK$8.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2120.HK's P/E ratio is 9.29. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2120.HK's ROE of +0.05%. Regarding short-term risk, 8161.HK is less volatile compared to 2120.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2120.HK's competition here
8161.HK vs 2389.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2389.HK has a market cap of 533.2M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2389.HK trades at HK$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2389.HK's P/E ratio is -4.40. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2389.HK's ROE of -0.07%. Regarding short-term risk, 8161.HK is less volatile compared to 2389.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2389.HK's competition here
8161.HK vs 2189.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2189.HK has a market cap of 455M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2189.HK trades at HK$0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2189.HK's P/E ratio is 22.75. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2189.HK's ROE of +0.16%. Regarding short-term risk, 8161.HK is less volatile compared to 2189.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2189.HK's competition here
8161.HK vs 1518.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1518.HK has a market cap of 439.2M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1518.HK trades at HK$0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1518.HK's P/E ratio is 8.18. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1518.HK's ROE of +0.09%. Regarding short-term risk, 8161.HK is less volatile compared to 1518.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1518.HK's competition here
8161.HK vs 0722.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 0722.HK has a market cap of 399.8M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 0722.HK trades at HK$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 0722.HK's P/E ratio is 10.00. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 0722.HK's ROE of +0.06%. Regarding short-term risk, 8161.HK is less volatile compared to 0722.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 0722.HK's competition here
8161.HK vs 1419.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 1419.HK has a market cap of 375.8M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 1419.HK trades at HK$0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 1419.HK's P/E ratio is 16.50. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 1419.HK's ROE of +0.03%. Regarding short-term risk, 8161.HK is less volatile compared to 1419.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 1419.HK's competition here
8161.HK vs 8405.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 8405.HK has a market cap of 276M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 8405.HK trades at HK$0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 8405.HK's P/E ratio is 9.86. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 8405.HK's ROE of +0.14%. Regarding short-term risk, 8161.HK and 8405.HK have similar daily volatility (0.00).Check 8405.HK's competition here
8161.HK vs 0286.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 0286.HK has a market cap of 251.6M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 0286.HK trades at HK$1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 0286.HK's P/E ratio is -0.86. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 0286.HK's ROE of -0.26%. Regarding short-term risk, 8161.HK is less volatile compared to 0286.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 0286.HK's competition here
8161.HK vs 2293.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2293.HK has a market cap of 233.4M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2293.HK trades at HK$0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2293.HK's P/E ratio is 9.67. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2293.HK's ROE of +0.11%. Regarding short-term risk, 8161.HK and 2293.HK have similar daily volatility (0.00).Check 2293.HK's competition here
8161.HK vs 8143.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 8143.HK has a market cap of 144.3M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 8143.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 8143.HK's P/E ratio is -12.80. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 8143.HK's ROE of -0.29%. Regarding short-term risk, 8161.HK is less volatile compared to 8143.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 8143.HK's competition here
8161.HK vs 8357.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 8357.HK has a market cap of 99.8M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 8357.HK trades at HK$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 8357.HK's P/E ratio is -16.00. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 8357.HK's ROE of -0.01%. Regarding short-term risk, 8161.HK is less volatile compared to 8357.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 8357.HK's competition here
8161.HK vs 8307.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 8307.HK has a market cap of 84.9M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 8307.HK trades at HK$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 8307.HK's P/E ratio is -21.40. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 8307.HK's ROE of -0.47%. Regarding short-term risk, 8161.HK and 8307.HK have similar daily volatility (0.00).Check 8307.HK's competition here
8161.HK vs 2135.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 2135.HK has a market cap of 72.4M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 2135.HK trades at HK$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 2135.HK's P/E ratio is -1.08. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 2135.HK's ROE of -0.21%. Regarding short-term risk, 8161.HK is less volatile compared to 2135.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8161.HK.Check 2135.HK's competition here
8161.HK vs 8437.HK Comparison August 2025
8161.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 8161.HK stands at 18.9M. In comparison, 8437.HK has a market cap of 9.7M. Regarding current trading prices, 8161.HK is priced at HK$0.46, while 8437.HK trades at HK$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
8161.HK currently has a P/E ratio of 2.39, whereas 8437.HK's P/E ratio is -0.45. In terms of profitability, 8161.HK's ROE is -2.14%, compared to 8437.HK's ROE of +0.20%. Regarding short-term risk, 8161.HK and 8437.HK have similar daily volatility (0.00).Check 8437.HK's competition here